Key result
Neomycin and carbodiimide cross-linking improves bioprosthetic valve biomechanics and reduces calcification without formaldehyde storage.
Why the study?
Glutaraldehyde cross-linking of bioprosthetic heart valves does not stabilize glycosaminoglycans, leading to their loss during preparation, implantation, fatigue, and storage.
Does neomycin and carbodiimide crosslinking improve durability and reduce calcification in bioprosthetic heart valves?
Does neomycin and carbodiimide crosslinking improve durability and reduce calcification in bioprosthetic heart valves?
Neomycin and carbodiimide crosslinking, combined with formaldehyde-free storage, may offer a more durable alternative to glutaraldehyde for bioprosthetic heart valves by improving GAG retention and reducing calcification.
Answers are grounded in this paper and cite their sources.
May support preclinical refinement of valve preservation; leaves open whether benefits translate to human durability.
Glutaraldehyde cross-linked porcine aortic valves, referred to as bioprosthetic heart valves (BHVs), are often used in heart valve replacements. Glutaraldehyde does not stabilize glycosaminoglycans (GAGs) and they are lost during preparation, in vivo implantation, cyclic fatigue, and storage. We report that binding of neomycin, a hyaluronidase inhibitor, to the tissues with carbodiimide cross-linking improves GAG retention without reducing collagen and elastin stability. It also led to improved biomechanical properties. Neomycin carbodiimide cross-linking did not significantly reduce calcification in a rat subdermal implantation model when they were stored in formaldehyde after cross-linking. Removal of formaldehyde storage significantly reduced calcification.
No takes yet. Share an insight, caveat, or question.
Leong et al. (2011) studied Bioprosthetic heart valve durability and calcification. Neomycin and carbodiimide cross-linking vs. Glutaraldehyde cross-linking was evaluated on Glycosaminoglycan retention, biomechanical properties, and calcification. Neomycin and carbodiimide cross-linking of bioprosthetic heart valves improved glycosaminoglycan retention and biomechanical properties, and reduced calcification when formaldehyde storage was removed.
Synapse has enriched 10 related papers. Consider them for comparative context: